Ozempic hair loss in London: why it happens and how to recover
GLP-1 medications are reshaping London's wellness scene — and trichology clinics are seeing a wave of shedding. Here is what is actually going on and what to do.
Dr. Amara Okafor
Consultant Trichologist · Harley Street
In short
- GLP-1 shedding is telogen effluvium — triggered by rapid weight loss and protein deficit, not the drug itself.
- Shedding peaks 3–4 months after the trigger and resolves in 6–9 months in most cases.
- Protein (1.2–1.6 g/kg/day), ferritin >70, and vitamin D >75 nmol/L are the three non-negotiables.
- London trichologists report 80%+ recovery when patients adjust nutrition before adding actives.
Walk into any Harley Street trichology clinic in 2026 and you will hear the same story on repeat: a patient on Ozempic, Wegovy or Mounjaro who has lost two stone and is now losing handfuls of hair in the shower. The shedding is real, but the diagnosis is almost never 'the drug caused this'.
What is actually happening is well-understood, treatable, and — for the vast majority of London patients — fully reversible.
Why GLP-1 medications trigger shedding
Rapid weight loss of any kind — surgical, dietary, pharmacological — pushes a disproportionate number of follicles from the growth phase (anagen) into the resting phase (telogen). About three months later, those resting follicles release their hairs all at once. This is classic telogen effluvium.
GLP-1s amplify the problem in two ways: dramatically reduced appetite means most patients under-eat protein, and the speed of weight loss outpaces what the body recognises as safe. The follicle responds by deprioritising hair growth in favour of essential metabolism.
The London recovery protocol
Across the clinics we work with in Marylebone, Kensington and the City, the recovery protocol is remarkably consistent:
- Protein: 1.2–1.6 g per kg bodyweight daily, spread across 3–4 meals. A 70 kg adult needs 85–110 g.
- Ferritin (stored iron) above 70 ng/mL — most women on GLP-1s drop below this within six months.
- Vitamin D above 75 nmol/L — non-negotiable in London given limited sun exposure.
- Zinc, B12, and omega-3 — measured at baseline, not guessed.
- Only after nutrition is corrected should topical minoxidil or microneedling be added.
When to see a trichologist
Book a consult if shedding has continued for more than four months, if you can see scalp where you could not before, or if hair diameter has visibly changed. A £120–£180 trichology consult with bloodwork is the fastest way to separate telogen effluvium from underlying androgenetic alopecia that the weight loss simply unmasked.
Frequently asked
Common questions
Will my hair grow back after Ozempic?+
In over 80% of cases yes — typically within 6–9 months of correcting protein intake and micronutrients. If shedding persists beyond a year, an underlying cause is likely.
Should I stop Ozempic if I am losing hair?+
Almost never the right first move. Speak to your prescriber, but the evidence points to nutrition and rapid weight loss as the trigger, not the drug itself.
Can I use minoxidil while on Ozempic?+
Yes — topical minoxidil is safe to combine, but trichologists typically wait until protein and ferritin are corrected to avoid masking the real issue.
Which London clinics specialise in GLP-1 hair loss?+
Several Harley Street and Marylebone trichology practices now run dedicated GLP-1 recovery protocols. Take the Hair Health Check for a personalised match.
Keep reading
Related, trichologist-reviewed
Hair loss
The early signs of hair loss in London — and the science-backed next move
Hair loss rarely announces itself. Here is how London trichologists separate normal shedding from the early signs that actually need action.
Read
Hair loss
Postpartum hair loss in London: what is normal, what isn't
Postpartum shedding affects up to 90% of new mothers. It is almost always temporary — but knowing the timeline matters, and so does knowing when to escalate.
Read
Hair loss
Female pattern hair loss in London: a specialist's 2026 guide
Female pattern hair loss is the most under-diagnosed common hair condition in the UK. The treatment options in 2026 are genuinely better — if you know to ask.
Read